We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAS
1876
DELISTED
Integral Ad Science
IAS
$352K ﹤0.01%
35,334
+9,537
+37% +$127K
ASC icon
1877
Ardmore Shipping
ASC
$707M
$352K ﹤0.01%
21,445
SLP icon
1878
Simulations Plus
SLP
$370M
$351K ﹤0.01%
8,535
INN
1879
Summit Hotel Properties
INN
$656M
$351K ﹤0.01%
53,912
-1,410
-3% -$9.2K
DXPE icon
1880
DXP Enterprises
DXPE
$3B
$349K ﹤0.01%
6,503
-842
-11% -$31.6K
LFST icon
1881
Lifestance Health
LFST
$4.67B
$349K ﹤0.01%
56,607
REVG
1882
DELISTED
REV Group
REVG
$349K ﹤0.01%
15,792
UNFI icon
1883
United Natural Foods
UNFI
$2.94B
$348K ﹤0.01%
30,310
-879
-3% -$12.8K
GDYN icon
1884
Grid Dynamics Holdings
GDYN
$644M
$347K ﹤0.01%
28,241
BLFS icon
1885
BioLife Solutions
BLFS
$1.72B
$347K ﹤0.01%
18,693
CASS icon
1886
Cass Information Systems
CASS
$750M
$347K ﹤0.01%
7,198
DX
1887
Dynex Capital
DX
$3.23B
$346K ﹤0.01%
27,821
OSG
1888
Octave Specialty Group
OSG
$212M
$346K ﹤0.01%
22,132
-2,434
-10% -$38.4K
NG icon
1889
NovaGold Resources
NG
$3.4B
$346K ﹤0.01%
115,288
-11,726
-9% -$33K
SIBN icon
1890
SI-BONE Inc
SIBN
$849M
$345K ﹤0.01%
21,105
SHOE
1891
Shoe Station Group
SHOE
$415M
$344K ﹤0.01%
9,400
AMTB icon
1892
Amerant Bancorp
AMTB
$1.14B
$344K ﹤0.01%
14,771
AMRX icon
1893
Amneal Pharmaceuticals
AMRX
$6.02B
$344K ﹤0.01%
56,708
-12,102
-18% -$68.2K
AGX icon
1894
Argan
AGX
$7.84B
$343K ﹤0.01%
6,793
BBUC
1895
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.01B
$343K ﹤0.01%
14,215
NRIX icon
1896
Nurix Therapeutics
NRIX
$2.82B
$342K ﹤0.01%
23,288
KNSA icon
1897
Kiniksa Pharmaceuticals
KNSA
$6.07B
$342K ﹤0.01%
17,349
DCOM icon
1898
Dime Commercial Bancshares
DCOM
$1.82B
$342K ﹤0.01%
17,770
LPRO
1899
DELISTED
Open Lending Corp
LPRO
$342K ﹤0.01%
54,618
JANX icon
1900
Janux Therapeutics
JANX
$978M
$341K ﹤0.01%
9,061
-1,553
-15% -$33.8K

Similar funds

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.